V

Vedere Bio II

24 employees

Vedere Bio is developing gene therapy products to restore functional vision to patients who have suffered vision loss.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2020

Funding rounds raised

Total raised

$77M

from 7 investors over 7 rounds

V

Vedere Bio II raised $77M on May 18, 2021

Investors: Octagon Capital Advisors, Samsara BioCapital, RD Fund, Casdin Capital, LLC and Atlas Venture

V

Vedere Bio II raised $21M on June 1, 2019

Investors: Mission BioCapital and Atlas Venture

FAQ